Maximus (MMS) Rating Increased to Weight at First Analysis

First Analysis upgraded shares of Maximus (NYSE:MMS) from an equal rating to a weight rating in a research note published on Tuesday, May 8th, Marketbeat reports. They currently have $81.00 price target on the health services provider’s stock, up from their prior price target of $73.00. First Analysis also issued estimates for Maximus’ Q1 2019 earnings at $0.96 EPS and FY2019 earnings at $3.91 EPS.

Other research analysts have also issued research reports about the stock. Zacks Investment Research upgraded shares of Maximus from a hold rating to a buy rating and set a $71.00 price objective for the company in a research note on Tuesday, February 13th. Canaccord Genuity dropped their target price on shares of Maximus from $71.00 to $65.00 and set a hold rating on the stock in a research report on Friday, February 9th. Finally, Maxim Group reissued a hold rating and set a $69.00 target price (up previously from $66.00) on shares of Maximus in a research report on Thursday, February 8th. One equities research analyst has rated the stock with a sell rating and four have assigned a hold rating to the company’s stock. The company currently has an average rating of Hold and an average price target of $71.00.

Shares of NYSE:MMS traded up $0.49 during trading hours on Tuesday, hitting $62.44. The company’s stock had a trading volume of 2,561 shares, compared to its average volume of 458,719. Maximus has a 52 week low of $61.51 and a 52 week high of $62.16. The firm has a market cap of $4.03 billion, a P/E ratio of 19.32, a P/E/G ratio of 2.38 and a beta of 1.13.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, May 10th. The health services provider reported $0.82 EPS for the quarter, missing the consensus estimate of $0.84 by ($0.02). The business had revenue of $612.79 million during the quarter, compared to the consensus estimate of $617.97 million. Maximus had a net margin of 9.15% and a return on equity of 21.67%. The company’s revenue for the quarter was down 1.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.80 EPS. sell-side analysts expect that Maximus will post 3.24 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 31st. Stockholders of record on Tuesday, May 15th will be issued a $0.045 dividend. This represents a $0.18 annualized dividend and a dividend yield of 0.29%. The ex-dividend date of this dividend is Monday, May 14th. Maximus’s dividend payout ratio (DPR) is currently 5.94%.

In other news, CEO Richard A. Montoni sold 30,000 shares of the company’s stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $67.89, for a total value of $2,036,700.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Richard A. Montoni sold 10,000 shares of the stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $67.42, for a total transaction of $674,200.00. The disclosure for this sale can be found here. Insiders sold a total of 41,000 shares of company stock worth $2,777,450 over the last ninety days. Insiders own 3.10% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Teacher Retirement System of Texas boosted its holdings in Maximus by 314.4% during the fourth quarter. Teacher Retirement System of Texas now owns 22,179 shares of the health services provider’s stock worth $1,588,000 after buying an additional 16,827 shares in the last quarter. BlackRock Inc. raised its position in Maximus by 1.6% during the fourth quarter. BlackRock Inc. now owns 6,674,541 shares of the health services provider’s stock worth $477,763,000 after acquiring an additional 107,376 shares during the period. Alliancebernstein L.P. raised its position in Maximus by 9.3% during the fourth quarter. Alliancebernstein L.P. now owns 178,939 shares of the health services provider’s stock worth $12,808,000 after acquiring an additional 15,200 shares during the period. Deutsche Bank AG raised its position in Maximus by 15.9% during the fourth quarter. Deutsche Bank AG now owns 284,516 shares of the health services provider’s stock worth $20,363,000 after acquiring an additional 38,960 shares during the period. Finally, MetLife Investment Advisors LLC acquired a new position in Maximus during the fourth quarter worth $5,071,000. 97.11% of the stock is currently owned by hedge funds and other institutional investors.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with's FREE daily email newsletter.

Leave a Reply